Searched for
REMUS PHARMACEUTICALS
ET Prime Special Series - Part 6: Management’s application of altered accounting rules, some right… some wrongThe last part of this series showed how financial numbers can shift not because the business has moved, but because the method of accountin...- Last day to buy NALCO, ONGC, 27 other stocks to qualify for dividend eligibility. Check list hereInvestors have a final chance today to buy shares in companies like NALCO and ONGC to receive interim and special dividends. The ex-date is...
- Ahead of Market: 10 things that will decide D-Street action on WednesdayBenchmark equity indices recovered to close flat on Tuesday, with gains in metal stocks offsetting declines in other sectors following top ...
- Corporate actions this week: Infosys, LTIMindtree to go ex-dividend, Shri Venkatesh Refineries ex-bonus and moreA company issues bonus shares for their shareholders in order to increase the liquidity of the stock as well as with the aim to decrease it...
- SME platform seeing flurry of listing actionSo far, in 2023, 100 SME firms have raised a record ₹2,600 crore of funds from the SME board, breaking the previous record of ₹2,287 crore ...
- Stock market update: Stocks that hit 52-week highs on NSEIKIO Lighting Ltd., Ambica Agarbathi, Lokesh Machines, GKW Ltd and Remus Pharmaceutic, hit their fresh 52-week highs at 11:21AM.
- Stock market update: Stocks that hit 52-week lows on NSEBharti Airtel, Bajaj Finserv, Bajaj Finance, Hero MotoCorp and Infosys were among the top losers on NSE.
- Stock market update: Nifty IT index advances 0.47% in an upbeat marketThe Nifty IT index was trading 0.47 per cent up at 28918.55.
- Stock market update: Nifty Realty index advances 0.76% in an upbeat marketThe Nifty Realty index was trading 0.76 per cent up at 509.35.
- SME IPO: Remus Pharmaceuticals gets muted response on Day 1. 8 key things to know about the issueRemus Pharmaceuticals is planning to raise Rs 47 crore through its initial share sale. The company is engaged in the business of marketing ...
Load More
